🇪🇺 antiviral therapy in European Union

EMA authorised antiviral therapy on 18 March 1998

Marketing authorisation

EMA — authorised 18 March 1998

  • Application: EMEA/H/C/000190
  • Marketing authorisation holder: ViiV Healthcare BV
  • Local brand name: Combivir
  • Indication: Combivir is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection.
  • Status: approved

Read official source →

Other Infectious Disease approved in European Union

Frequently asked questions

Is antiviral therapy approved in European Union?

Yes. EMA authorised it on 18 March 1998.

Who is the marketing authorisation holder for antiviral therapy in European Union?

ViiV Healthcare BV holds the EU marketing authorisation.